The programme of this event will be accredited with ESMO-MORA category 1 points. Please be aware that visa costs are NOT covered by the travel grant and are the participant's responsibility. The reimbursement will be processed after the course against original invoices/vouchers. In addition to the course registration and the hotel accommodation, a travel grant of maximum 600 euros is offered to selected applicants as a contribution versus their travel costs. Successful applicants will benefit from complimentary course registration and accommodation. Participants are strongly advised to take out their own personal and travel coverage. InsuranceĮSMO bears no responsibility for any untoward events in connection with, before, during and after the course. *Any changes to the COVID-19 regulations will be communicated on this webpage.

All surfaces will be disinfected on a regular basis.

Hand sanitiser will be available at the hotel.

The individual safety and hygiene measures of all participants is our priority, so we implemented additional measures on-site at the venue:

Avoid shaking hands wash your hands regularly and use hand sanitiser.

Testing for COVID-19 within 48 hours prior to the inbound trip with a molecular, rapid antigen or self-test.

Vaccination proof will not be checked by ESMO. ESMO COVID-19 RegulationsĮach participant needs to check and comply with the latest health and travel regulations to ensure a fast and easy journey.ĮSMO requires that all attendees are fully vaccinated against COVID-19 OR recovered in the last 6 months with at least one dose of a vaccine by the time of the meeting. If you are not an ESMO member or need to renew your membership, please visit the ESMO membership pages. While this course is primarily aimed at oncologists resident in Europe, application is open to all ESMO members.

3-5 slides presenting a clinical case (please use the ESMO Preceptorship Case Presentation Power Point template, provided here)Īpplications for the course will close on 7 September 2023.

Your CV including a list of your publications.

During the application process you will be required to upload the following:

To familiarize with current treatment paradigms in SCLC, mesothelioma, and thymoma/thymic carcinomaĪpplication is via online form.

To understand the complex picture of immunotherapy and targeted therapies for lung cancer in 2023.

To understand current landscape of multimodality treatment of stage I - III lung cancer.

To learn the principles of pathology, molecular testing, and screening of lung cancer.

Download сентябрь 2023 года